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Recent genomic analyses of transcription factor binding, histone modification, and gene expression have
provided a global view of transcriptional regulation by nuclear receptors (NRs) that complements an existing
large body of literature on gene-specific studies.The picture emerging from these genomic studies indicates
that NRs bind at promoter-proximal and promoter-distal enhancers in conjunction with other transcription
factors (e.g., activator protein-1, Sp1 and FOXA1).This binding promotes the recruitment of coregulators that
mediate the posttranslational modification of histones at promoters and enhancers. Ultimately, signaling
through liganded NRs stimulates changes in the occupancy of RNA polymerase II (Pol II) or the activation of
preloaded Pol II at target promoters. Chromosomal looping and/or Pol II tracking may underlie
promoter-enhancer communication. Interestingly, the direct target genes of NR signaling represent a limited
subset of all the genes regulated by NR ligands, with the rest being regulated through secondary effects. As
suggested by previous gene-specific analyses, NR-mediated outcomes are highly cell type- and
promoter-specific, highlighting the complexity of transcriptional regulation by NRs and the value of genomic
analyses for identifying commonly shared patterns. Overall, NRs share common themes in their patterns of
localization and transcriptional regulation across mammalian genomes. In this review, we provide an overview
of recent advances in the understanding of NR-mediated transcription garnered from genomic analyses of
gene expression, factor localization, and target DNA sequences.
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Introduction
The spatial and temporal regulation of gene expression
is an important means by which cells respond to
physiological and environmental signals. DNA-binding
transcription factors, non-DNA-binding coregulators, and
the RNA polymerase II (Pol II) machinery are important
for mediating proper (i.e., context-specific or
developmentally appropriate) patterns of gene expression
[Naar et al., 2001; Orphanides and Reinberg, 2002].
Nuclear receptors (NRs) comprise a superfamily of
ligand-regulated, DNA-binding transcription factors, which
can both activate and repress gene expression
[Mangelsdorf et al., 1995]. Given the number of related
factors in the superfamily (49 NR genes and more than
75 NR proteins in mammals; [Robinson-Rechavi et al.,
2001]) and their physiological roles throughout the body,
NRs make an interesting model to study the mechanisms
of transcriptional regulation in response to cellular signals.
Transcriptional regulation by NRs is a multistep process
involving: (1) the association of NRs with regulatory sites
in the genome (i.e., enhancers or silencers) in the context
of chromatin, (2) the ligand-dependent recruitment and
function of coregulators to modify chromatin and
associated factors, (3) the regulation of Pol II binding and
activity at target promoters, and (4) the termination or
attenuation of NR-dependent signaling [Acevedo and
Kraus, 2004; Glass and Rosenfeld, 2000; Kraus and
Wong, 2002; McKenna et al., 1999; Metivier et al., 2006].
The complexity of transcriptional regulation by NRs
provides many opportunities for exquisite regulatory
control of signal-dependent transcriptional responses.
The mechanisms of transcriptional regulation by
ligand-bound NRs have been studied extensively in
numerous gene-specific studies over the past 30 years.
Recently, the development of large-scale genomic
methods to analyze gene expression and factor binding
to DNA has generated an extensive amount of information
about NR-regulated transcription. Some of these methods
(i.e., gene expression microarray analyses, ChIP-chip,
in silico binding site analyses) have been reviewed
recently elsewhere [Kim and Ren, 2006;Tavera-Mendoza
et al., 2006]. Here, we provide an overview of recent
advances in our understanding of NR-mediated
transcription focusing on genomic analyses of gene
expression, factor localization, and target DNA
sequences.
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Gene expression microarrays have been widely used to
determine genes whose expression changes upon
treatment with NR ligands, such as estrogens, androgens,
glucocorticoids, vitamin D3, and lipid metabolites [Frasor
et al., 2003; Lee et al., 2003; Quinn et al., 2005; Rogatsky
et al., 2003;White, 2004]. Due to the large number of
studies available, we will use the regulation of gene
expression by ER ligands as an example to illustrate the
use of expression microarrays to understand global
features of NR-mediated transcription.The approaches
and key concepts are similar for most global NR-mediated
gene expression studies to date.
How many genes are regulated by estrogen
signaling?
The first question addressed by expression microarray
analyses of estradiol (E2)-dependent gene expression
was "How many genes are regulated by E2 in human
cells?" The answer turned out to be less straightforward
than expected, and several studies currently available
report different numbers of E2-regulated genes, ranging
from ∼100 to ∼1,500 [Carroll and Brown, 2006; Coser et
al., 2003; Frasor et al., 2003; Kian Tee et al., 2004; Kininis
et al., 2007; Kwon et al., 2007; Levenson et al., 2002; Lin
et al., 2004; Lin et al., 2007; Monroe et al., 2003; Rae et
al., 2005; Stender et al., 2007] (Table 1).These
discrepancies can be attributed to many factors including
differences in: (1) the cell lines (tissue origin, ER
expression, and growth conditions), (2) the length of the
E2 treatment, (3) the microarray platforms and associated
experimental variability, and (4) the data analysis
protocols. Examples of such types of variation among
recent global E2-dependent gene expression analyses
are shown in Table 1.
Global features of E2-regulated gene expression
Despite the differences noted above, genomic analyses
of E2-regulated gene expression have provided a wealth
of useful information for understanding the global features
of NR-mediated gene expression. In summary, genomic
expression analyses have indicated that: (1) only a limited
subset (20-30%) of the E2-regulated genes represent
direct E2 targets, as shown by co-treatment with the
translation inhibitor cycloheximide [Lin et al., 2004]; (2)
the majority of E2-regulated genes after short (1-8 h)
hormone treatments are upregulated, whereas most
genes regulated after longer treatments (12-48 h) are
downregulated [Frasor et al., 2003; Lin et al., 2004]; (3)
a surprisingly limited overlap exists between the gene
sets regulated by E2 in different cell lines (and even the
same cell line grown in different laboratories) [Carroll and
Brown, 2006; Frasor et al., 2003; Kininis et al., 2007; Lin
et al., 2004; Rae et al., 2005; Stender et al., 2007] (also
see Supplemental Table 1 in Kininis et al. [Kininis et al.,
2007]); (4) the two subtypes of ER (ERα and ERβ)
regulate diverse (>70% different) sets of genes [Kian Tee
et al., 2004; Monroe et al., 2003]; (5) selective estrogen
receptor modulators (SERMs) have both antagonistic and
agonistic effects on global patterns of gene expression,
in some cases overlapping with E2-regulated gene sets
[Frasor et al., 2004; Levenson et al., 2002]; and (6) some
E2-regulated genes are dependent on other DNA-bound
transcription factors, such as AP-1, for their expression
[DeNardo et al., 2005]. Collectively, the available gene
expression microarrays have revealed new global features
of NR-mediated transcription, complementing previous
gene-specific studies.
Facilitating comparisons between different
studies of NR-regulated gene expression
Although it may be unrealistic to expect all researchers
in the NR field to follow the same experimental protocols
(e.g., RNA processing, microarray platform and handling,
and data analysis), means are available to facilitate
comparisons among different studies of NR-regulated
gene expression. One approach is to evaluate expression
microarray performance using complementary
approaches, such as Northern blotting or quantitative
reverse transcription-PCR, with clear reporting of the
confirmation rates [Tan et al., 2003;Taniguchi et al.,
2001]. Although this approach would help to control for
false positives introduced by the microarray experimental
variability, it would not account for false negatives (i.e.,
genes whose expression changes in the experimental
samples, but is not detected by the microarrays). A
second simple approach would be to use external
controls, such as RNA molecules synthetically produced
and spiked in defined amounts to biological samples
before hybridization to microarrays [van Bakel and
Holstege, 2004]. By using this protocol, differences in
microarray sensitivity could be assessed, and proper
normalization could be applied to the data. Furthermore,
a direct comparison of each study’s results to previously
published data would greatly facilitate our understanding
of the extent and sources of variation. Finally, the
deposition of raw (i.e., unprocessed) datasets in
databases, such as GEO
(http://www.ncbi.nlm.nih.gov/geo/) or NURSA
(http://www.nursa.org/), would facilitate meta-analysis
efforts aiming to compare and contrast data from different
studies using the same analysis algorithms.
Global studies of NR localization
A number of recent studies determined the genomic
binding sites of several NRs, including ERα, AR, GR,
VDR, ERRα, and ERRβ. Given that most of these studies
have focused on the localization of ERα, either to gene
promoters, chromosomes, or the whole human genome
[Carroll et al., 2005; Carroll et al., 2006; Cheng et al.,
2006; Gao et al., 2008; Jin et al., 2004; Kininis et al.,
2007; Kwon et al., 2007; Laganiere et al., 2005a;
Laganiere et al., 2005b; Lin et al., 2007] ( Table 2), we
will mainly focus our review on ERα and compare the
ERα-specific conclusions to findings about other NRs.
The existing studies used a wide variety of chromatin
immunoprecipitation (ChIP)-based methods, including
combinations of ChIP with microarrays (e.g., ChIP-chip
and ChIP-DSL) and with DNA sequencing (e.g.,
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ChIP-cloning and ChIP-PET) ( Table 3), and the results
have not always been consistent.
Similarities and differences among the available
genomic ERα location analyses
Remarkably, all genomic analyses of ERα localization
performed to date in human cells used the same cell line
(MCF-7) and most of them used a similar length of E2
treatment (∼45 min.) (Table 2). However, the overlap of
ERα binding sites among these studies is strikingly
limited. For example, only 624 of the 1,234 (50.6%)
ChIP-PET ERα binding sites identified by Lin et al., 2007
[Lin et al., 2007] were common to the 3,665 ChIP-chip
ERα binding sites identified by Carroll et al., 2006 [Carroll
et al., 2006], representing an overlap of less than 20%
for the union of ERα binding sites from the two studies.
In addition, only one common ERα-bound promoter
(TFF1) from the overlapping chromosome 21 and 22
promoter set was identified in two recent ChIP-chip
studies, although the same antibody was used [Carroll
et al., 2005; Laganiere et al., 2005b;Tavera-Mendoza et
al., 2006]. Some of these differences may be attributed
to the specific microarray platform used and other
experimental variations, but cross-validation of the
conflicting results in the available experimental systems
is necessary to determine whether the overlap or the
union of the identified binding sites represents more
accurately the true landscape of ERα targets in MCF-7
cells.
Despite their differences, the ERα localization studies
mentioned collectively provide an increasingly clearer
view of the general patterns of ERα binding across the
genome. For many E2-regulated genes, the ERα binding
sites are located at great distances (>100 Kb) from target
promoters, while for other E2-regulated genes, the
receptor binding sites are located within or near proximal
promoter regions [Carroll et al., 2006; Kininis et al., 2007;
Kwon et al., 2007; Laganiere et al., 2005b; Lin et al.,
2007]. A recent study in mice confirmed the binding of
ERα both proximally and distally from promoters in vivo
[Gao et al., 2008]. Interestingly, genes upregulated by
E2 contain more promoter-proximal ERα binding sites
than genes downregulated by E2 [Kininis et al., 2007;
Kwon et al., 2007; Lin et al., 2007]. Furthermore, genes
upregulated by shorter E2 treatments are enriched in
ERα binding sites adjacent to their promoters in contrast
to genes upregulated by longer E2 treatments, suggesting
secondary regulatory effects for the latter gene set [Kininis
et al., 2007; Kwon et al., 2007; Lin et al., 2007]. In some
cases, ERα-bound distal enhancers were shown to
physically interact with the nearest promoters, presumably
regulating their E2-dependent expression [Carroll et al.,
2005].The available genomic studies suggest that this
long-range regulation may be particularly important for
some subsets of genes. Further studies are needed,
however, to understand the role of ERα binding to distal
enhancers and the generality of the proposed
enhancer-promoter looping mechanisms.
Genomic localization themes shared by NRs
In addition to ERα, recent ChIP-chip analyses have
examined the localization of AR, GR, VDR, ERRα, and
ERRγ at selected regions of the human genome [Bolton
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Table 3.  ChIP-based methods to study factor localization on a genomic scale. A number of recent studies have determined the genomic
binding sites of several NRs. Important technical features, as well as advantages and disadvantages of each method, are summarized.
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al., 2007;Wang et al., 2007].The global features of AR,
GR and VDR binding to DNA are remarkably similar to
those identified for ERα in that the receptors localize both
distally and proximally to gene promoters, and
enhancer-promoter looping may be an important mode
of transcriptional regulation [Pike et al., 2007; So et al.,
2007;Wang et al., 2007].The ERR location analysis
focused on gene promoters and identified a significant
overlap in the ERRα- and ERRγ-bound targets,
suggesting that the two ERR subtypes may function as
heterodimers in human cells [Dufour et al., 2007]. Overall,
NRs share some common themes in their patterns of
localization across the human genome (i.e.,
promoter-proximal and promoter-distal binding, long-range
enhancer-promoter interactions), although more studies
covering a wider range of NRs are needed to fully
establish the generality of these patterns.
NR binding sites: lessons from the
underlying DNA sequences
Gene-specific studies have shown that NRs can associate
with their target DNA sequences through at least two
different mechanisms: (1) direct binding to specific
response elements as monomers, homodimers, or
heterodimers [Klein-Hitpass et al., 1988; Mangelsdorf et
al., 1995], and (2) indirect binding (or "tethering") through
other classes of DNA-bound transcription factors (e.g.,
activator protein-1, AP-1) [Kushner et al., 2000]. In
addition to directing NRs to specific regions of the
genome, the target DNA sequences can also regulate
the specificity of NR-mediated responses [Klinge et al.,
2004; Kurokawa et al., 1995; Lefstin and Yamamoto,
1998; Loven et al., 2001; O'Lone et al., 2004; So et al.,
2007]. Interestingly, although the NR binding sequences
may vary extensively from a consensus, the precise
sequences at individual NR binding sites are often well
conserved among mammalian species [So et al., 2007].
Furthermore, the direct or indirect association of NRs with
their target sites may allosterically regulate receptor
activity and coregulator recruitment [Shang and Brown,
2002].
Many of the recent genome-wide localization studies have
used bioinformatic approaches to search for common
motifs in the DNA sequences underlying the identified
binding sites. As expected, estrogen-, androgen-,
glucocorticoid-, vitamin D3- and estrogen
related-response elements (EREs, AREs, GREs, VDREs
and ERREs, respectively) were enriched in the binding
sites of their cognate NRs [Carroll et al., 2005; Carroll et
al., 2006; Cheng et al., 2006; Dufour et al., 2007; Gao et
al., 2008; Kininis et al., 2007; Kwon et al., 2007; Laganiere
et al., 2005b; Lin et al., 2007; Pike et al., 2007; So et al.,
2007;Wang et al., 2007]. Notably, for ERRα and ERRγ,
the same consensus ERRE sequence was found for both
receptor subtypes, consistent with the binding of these
receptors as heterodimers to common sites [Dufour et
al., 2007]. In addition to NR response elements, binding
elements for various other transcription factors (e.g.,
AP-1, Sp1, FOXA1, Oct1, CREB, C/EBPα, Myc) were
also enriched in NR binding sites [Carroll et al., 2005;
Carroll et al., 2006; Cheng et al., 2006; Dufour et al.,
2007; Gao et al., 2008; Kininis et al., 2007; Laganiere et
al., 2005b; Lin et al., 2007;Wang et al., 2007]. In some
cases, the binding elements for the transcription factors
were found adjacent to NR response elements (e.g.,
FOXA1, Myc, SF1, and PAX3 with ERα) [Carroll et al.,
2005; Cheng et al., 2006; Laganiere et al., 2005b; Lin et
al., 2007], while in other cases, they were found in lieu
of NR response elements (e.g., AP-1 with ERα) [Carroll
et al., 2006; Kininis et al., 2007].This latter result provides
genomic support for the existence of a tethering
mechanism in vivo. Gene-specific ChIP assays have
confirmed the binding of the transcription factors to their
cognate elements, while RNAi-mediated knockdown and
mutagenesis of the binding element has demonstrated a
role for these transcription factors in ligand-mediated
signaling by NRs [Carroll et al., 2005; Carroll et al., 2006;
Cheng et al., 2006; Dufour et al., 2007; Kininis et al.,
2007; Laganiere et al., 2005b; Lin et al., 2007;Wang et
al., 2007]. Collectively, the combination of bioinformatic
sequence analyses and experimental validation has
greatly extended our understanding of NR binding to DNA
and associated crosstalk with other signaling pathways.
Connecting NR binding to gene
expression through RNA Pol II
Although the mechanisms of NR binding to cognate
binding sites have been well characterized, the underlying
mechanisms connecting NR functions to Pol II activity at
target promoters are less well understood. Gene-specific
studies examining ligand-dependent changes in Pol II
occupancy at a limited set of NR-regulated promoters
have provided a view of Pol II regulation by NRs that is
usually assumed to be true for all NR-regulated genes.
In this “classical” view, the binding of NRs and associated
coregulators to enhancers ultimately regulates the
recruitment of Pol II and general transcription factors to
target promoters, thus modulating the expression of the
associated genes [Dilworth and Chambon, 2001;
McKenna et al., 1999; Metivier et al., 2006; Orphanides
et al., 1996] (Figure 1).To examine the generality of this
view, several studies have used ligand-treated cells to
examine the localization of Pol II to NR-regulated genes
using ChIP-chip [Carroll et al., 2006; Kininis et al., 2007;
Kwon et al., 2007].These analyses, summarized in Table
4, have addressed two important questions: (1) where
does Pol II bind and (2) how are Pol II binding and activity
regulated by NR signaling.
Pol II binding at promoters and distal enhancers
As expected, genome-wide studies showed that in
E2-treated cells, Pol II was localized to the proximal
promoter regions of most E2-stimulated genes [Carroll
et al., 2006; Kininis et al., 2007; Kwon et al., 2007]. In
some cases, however, Pol II was also bound to distal
ERα enhancers [Carroll et al., 2006; Kininis et al., 2007;
Kwon et al., 2007]. Based on gene-specific studies with
ER- and AR-regulated genes, two models have been
proposed for the actions of Pol II at distal enhancers. In
the first, Pol II is thought to track from a promoter-distal
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liganded NRs to promoter-proximal and promoter-distal enhancers in conjunction with other transcription factors (e.g., AP1, Sp1 and FOXA1), (2) the
ligand-dependent recruitment and actions of coregulators (coactivators and corepressors) to modify chromatin and associated factors, and (3) the
regulation of Pol II binding or the activation of preloaded Pol II at target promoters.
Table 4.  Genomic analyses of RNA polymerase II localization in human cell lines. Table summarizing the similarities and differences among
genomic analyses of RNA polymerase II localization in E2-treated (I) and steady-state (II) human cells.
enhancer to the transcriptional start site (TSS) upon
treatment with ligand [Louie et al., 2003;Wang et al.,
2005]. In the second, enhancer-bound Pol II associates
with the TSS through chromosomal looping [Carroll et
al., 2005]. Although these suggestions are intriguing, it
is difficult to eliminate the possibility that the Pol II
detected at distal enhancers results from (1) crosslinking
of the enhancers with Pol II-bound promoters (as opposed
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(2) the presence of unannotated TSSs throughout the
genome [Birney et al., 2007; Hatzis and Talianidis, 2002].
Furthermore, the analysis of Pol II localization only after,
but not before, treatment with NR ligands in many of the
available studies increases the difficulty in assessing the
ligand-dependent effects of NR signaling on Pol II function
(see Table 4, Part I).
Regulation of Pol II binding and activity by NR
signaling
As noted above, in the “classical” view of NR-regulated
transcription, the binding of NRs and coregulators to
enhancers regulates the ligand-dependent recruitment
of Pol II to target promoters and modulation of gene
expression [Dilworth and Chambon, 2001; McKenna et
al., 1999; Metivier et al., 2006; Orphanides et al., 1996].
However, recent genomic analyses have indicated that
stable Pol II-containing complexes exist at the promoters
of many unexpressed genes prior to activation (Table 4,
Part II) [Barski et al., 2007; Guenther et al., 2007; Kim et
al., 2005; Radonjic et al., 2005]. Accordingly, a recent
genomic analysis of Pol II occupancy in both the presence
and absence of E2 identified E2-stimulated genes with
"preloaded" Pol II at their promoters prior to gene
activation [Kininis et al., 2007]. For these genes, E2
signaling stimulates the phosphorylation, but not the
recruitment, of Pol II, promoting transcription elongation
through the gene rather than transcription initiation. In
this regard, NRs, including ERα, have been shown to
interact with proteins that regulate Pol II phosphorylation
and activity [Aiyar et al., 2004; Kinyamu and Archer, 2007;
Wittmann et al., 2005]. Although the generality of this
mechanism remains to be determined, it is intriguing to
suggest that, in some cases, NRs may control gene
expression by regulating the activity, and not the
recruitment, of Pol II at target promoters, as shown for
other DNA-bound transcription factors [Saunders et al.,
2006] (Figure 1).
Defining the direct target genes of NR signaling
As the first genomic analyses of NR-regulated gene
expression showed, ligand-dependent regulation of gene
expression itself is not sufficient to distinguish between
direct and secondary targets of NR signaling. Over the
past few years, genomic studies have used various
criteria to define the direct target genes of NR signaling,
including: (1) regulation of gene expression by short
treatments with ligand [Frasor et al., 2003; Lin et al.,
2004]; (2) dependence of gene regulation on the
receptors, as determined by receptor antagonists and
siRNA-mediated knockdown of NRs [Lin et al., 2004;
Wang et al., 2004]; (3) identification of NR binding sites
at candidate promoters [Kwon et al., 2007; Lin et al.,
2007]; (4) loss of ligand-regulated gene expression after
co-treatment with protein translation inhibitors [Lin et al.,
2004; Rogatsky et al., 2003]; and (5) evidence for
changes in Pol II promoter occupancy (an early step in
transcriptional regulation) prior to changes in mRNA
accumulation [Kininis et al., 2007]. Although each of the
above criteria alone is not sufficient, their use in
combination can provide a powerful means for
determining the direct genomic effects of NRs and their
ligands on gene expression.
Genomic analyses of coregulator
localization and chromatin modifications
After binding to their genomic targets, NRs mediate their
ligand-dependent actions by recruiting positive or negative
coregulators.These coregulators, which are shared by
various other DNA-binding transcription factors, include:
(1) histone- and factor-modifying enzymes, such as the
histone acetyltransferase p300 and the histone
demethylase LSD1, and (2) bridging factors, such as the
steroid receptor coactivators (SRCs), which function to
recruit the histone- and factor-modifying enzymes to
ligand-bound receptors [Jepsen and Rosenfeld, 2002;
Lonard and O'Malley, 2006; McKenna et al., 1999; Perissi
and Rosenfeld, 2005]. Although the ligand-dependent
recruitment and release of NR coregulators has been
examined in detail for a number of genes, the localization
of NR coregulators on a global scale has not been studied
extensively.
The available genomic localization studies for NR
coregulators, including SRCs, p300/CBP, and LSD1, have
provided an initial view of the global function of these
factors with respect to NR-dependent signaling. All of the
aforementioned NR coregulators were found to bind to
both promoter-proximal and promoter-distal regions,
mirroring the binding patterns observed for NRs [Gamble
and Kraus, 2007; Garcia-Bassets et al., 2007; Heintzman
et al., 2007; Kininis et al., 2007; Kwon et al., 2007;
Labhart et al., 2005]. In recent studies, nearly all of the
SRC-bound sites were also occupied by ERα, suggesting
a strong link between the recruitment of coregulators and
the binding of NRs to sites across the genome [Kininis et
al., 2007; Labhart et al., 2005]. A given NR coregulator,
however, is not located at all NR binding sites, suggesting
that NRs recruit a variety of coregulators in a target
gene-specific manner [Garcia-Bassets et al., 2007; Kininis
et al., 2007]. Accordingly, the correlation between ERα
and SRC recruitment held only for E2-stimulated genes,
and no SRC was detected at the promoters of
E2-repressed genes [Kininis et al., 2007]. Further studies
are necessary to understand the mechanisms regulating
the selective recruitment of coregulators to some, but not
other, NR binding sites in the same cell.
In addition to studying the localization of histone-modifying
coregulators, several studies have examined the state of
chromatin, as indicated by histone modifications, at
promoters of NR-regulated genes. Histone modifications,
such as acetylation and methylation, can regulate
NR-mediated transcription by creating (1) a chromatin
landscape more or less favorable to gene expression and
(2) binding sites on histones for regulatory proteins, with
specific modifications specifying transcriptional activation
or transcriptional repression [Fischle et al., 2003;
Jenuwein and Allis, 2001; Seet et al., 2006;
Shogren-Knaak et al., 2006]. Acetylation of histones,
primarily H3 acetylated at lysines 9 and 14 (AcH3K9/14),
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promoter-distal ERα binding enhancers [Kininis et al.,
2007; Kwon et al., 2007].The ligand-dependent changes
in histone acetylation at the promoters of E2-stimulated
or -repressed genes correlated with Pol II recruitment or
release, respectively [Kininis et al., 2007]. In contrast to
histone acetylation, histone methylation showed a more
complicated pattern.While some histone methylation
marks for active genes (e.g., H3 mono- and di-methylated
at lysine 4 ; H3K4me1 and H3K4me2) were detected at
both promoter-proximal and promoter-distal enhancers,
other marks for active genes (e.g., H3 tri-methylated at
lysine 4; H3K4me3) were found exclusively at
promoter-proximal NR binding sites [Kwon et al., 2007],
as reported for other DNA-bound transcription factors
[Barski et al., 2007; Guenther et al., 2007; Heintzman et
al., 2007]. Furthermore, histone methylation marks
previously associated with inactive genes (e.g., H3
tri-methylated at lysine 9 and H3 di-methylated at lysine
79; H3K9me3 and H3K79me2, respectively) were
enriched in some NR-regulated genes after gene
activation, suggesting that the role of these modifications
is more complicated than previously thought [Kwon et al.,
2007]. Interestingly, the ratio of AcH3K9 to H3K9me2 at
promoters was shown to be a good marker for ERα
recruitment and E2-dependent regulation of gene
expression [Cheng et al., 2006]. Collectively, these results
suggest that NR signaling regulates the chromatin state
of its genomic targets through histone modification.
Certain modifications, however, have distinct
gene-specific roles and their effects on gene expression
cannot be generalized [Berger, 2007].
Summary and future perspectives
Recent genomic analyses of transcription factor binding,
histone modification, and gene expression have provided
a global view of transcriptional regulation by NRs, which
complements the existing literature of gene-specific
studies.These genomic analyses have revealed some
common themes for the molecular regulation of gene
expression by NRs.These themes include: (1) direct or
indirect binding of NRs at promoter-proximal and
promoter-distal enhancers in conjunction with other
transcription factors (e.g., AP-1, Sp1 and FOXA1), (2)
NR-dependent recruitment of coregulators and
subsequent modification of histones at both enhancers
and promoters, and (3) ultimately, NR-dependent
regulation of the recruitment of Pol II or the activity of
preloaded Pol II at the promoters of target genes.This
regulation may be facilitated by chromosomal looping
and Pol II tracking, which can promote the
enhancer-promoter communication. Overall, the direct
targets of NR signaling seem to be limited to a subset of
all the genes regulated by NR ligands, with the rest likely
to be regulated through secondary effects. In addition,
NR-dependent gene regulation occurs in a highly cell
type- and promoter-specific manner, indicating the
complexity of transcriptional regulation by NRs and the
value of genomic analyses in identifying commonly shared
patterns. Despite their differences, NRs share common
themes in their patterns of localization and transcriptional
regulation in the human genome. Further studies are
needed to confirm the generality of these patterns and
examine the associated mechanisms in more detail.
Although the global picture of NR-mediated transcription
provided by the studies described herein has advanced
our understanding of NR-dependent transcription, many
questions remain unanswered and new ones have
emerged from the wealth of available genomic data. One
of the key challenges in the NR field today is to determine
the in vivo functionality of NR binding sites that have been
identified in genomic analyses, especially with respect to
enhancer-promoter interactions and cell type-specificity.
A common theme from the numerous available chromatin-
and transcription-related genome-wide factor localization
analyses is that the binding of a factor to a specific site
in the genome does not always correlate in an obvious
way with a functional outcome for a specific target gene
(as determined, for example, by RNAi-mediated
knockdown of the relevant factor, coupled with
gene-specific expression analyses). In some cases, a
particular binding event may only have a detectable
functional outcome in a particular cell type.Thus,
validation of the functionality of individual NR binding sites
in vivo is essential (e.g., by mutating the associated DNA
elements in their native genomic and chromatin
environment and examining the outcome in cells and
animals).
A number of other areas of NR biology will benefit from
additional genomic analyses. For example, ongoing efforts
to map long-range interactions between distal NR binding
sites and target promoters on a genomic scale should
greatly facilitate our understanding of target genes
regulated by NR binding. Moreover, additional genomic
studies of NR coactivator and corepressor localization
will help to provide a broader picture of the
ligand-dependent effects of NR binding to genomic sites.
Furthermore, genomic analyses of factors involved in the
tethering of NRs to target enhancers (e.g., such as AP-1
and NF-κB) will provide new insights into this poorly
understood, but physiologically important, mechanism.
Finally, additional global analyses of Pol II localization
and activity are needed to determine the generality of Pol
II recruitment and Pol II activation at NR-regulated genes.
Collectively, genomic analyses of gene expression, factor
localization, and target DNA sequences provide a new
set of tools for examining the generality of previously
studied mechanisms, as well as identifying new
mechanisms by which NRs mediate their physiologically
important actions.
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